Unfortunately it is an "all or nothing" approach (which I personally do not necessarily agree with this approach). If you market in those countries, they must be included in the scope of MDSAP whether you want it or prepared for it. Dan gave a good example, if you do not market your product in 2 countries and market in 3 countries, those 3 countries must all be included in scope.
Therefore, to comply with Health Canada requirement by the end of 2018, MDSAP audit is required. If you also sell in U.S., Brazil, and Australia - you will get your MDSAP certificate for Health Canada, but then the AO audit report will also be sent to FDA, ANVISA, and TGA. There are pros and cons, because as example you may not get a routine inspection from FDA or can leverage the AO audit report to preclude an ANVISA GMP inspection for Class III and IV device. However, if you have a bad audit (poor auditor) then all of these regulatory entities will get that audit report ... which may instigate a "for cause" inspection.
------------------------------
Richard Vincins RAC
Vice President Regulatory Affairs
------------------------------
Original Message:
Sent: 01-Dec-2017 16:41
From: Joy Pelfrey
Subject: MDSAP Scope Clarification
Hello All,
I have had conflicting answers to a question regarding the scope of an MDSAP audit. If you have an MDSAP audit, can the manufacturer define and limit the scope to just one country (i.e.Canada) or is an MDSAP auditor required to audit to all 5 countries' regulations and report results to all 5 countries?
Thanks for your insight!
Joy
------------------------------
Joy Pelfrey
Director of RA/QA
Norman OK
United States
------------------------------